Medicine

Santhera Announces Approval of Raxone® for LHON in Israel

The Centers for Disease Control and Prevention (CDC) recently released its annual National Diabetes Statistics Report, and the results remind us that better education about the symptoms and treatment for the disease is needed. 

Sanofi announced today that it has completed the acquisition of Protein Sciences, a vaccines biotechnology company based in Meriden, Connecticut in the United States

Kuros receives clearance for MagnetOs Putty for commercialization in the United States and files the product for CE marking in Europe

Last flu season, vaccination rates for kids may have fallen because the CDC warned parents away from nasal spray versions.

Novartis Kisqali® (ribociclib) receives EU approval as first-line treatment for HR+/HER2- locally advanced or metastatic breast cancer in combination with any aromatase inhibitor

Novartis and Medicines for Malaria Venture launch patient trial in Africa for KAF156, a novel compound against multidrug-resistant malaria

More than 500,000 people in Yemen are suspected of having cholera, the United Nations health agency today said, warning that the disease is spreading quickly due to a lack of clean water or health access.

"...these medications continue to be broadly promoted and marketed, even in light of the accelerating opioid epidemic in the US."

Opponents of the Affordable Care Act say the law hurts the job market. These economists disagree.

− Pivotal Phase 3 BOSTON Study Underway –

Completed US IPO

Takeda Pharmaceutical Company Limited (TSE: 4502) and Molecular Templates, Inc. today announced a collaboration agreement for oncology drug discovery programs.

Takeda Pharmaceutical Company Limited (TSE: 4502) and Cardurion Pharmaceuticals today announced the creation of a new cardiovascular development partnership.